Carotid Artery Stenosis

Slides:



Advertisements
Similar presentations
Preventing Strokes One at a Time Acute Interventions and Management 2009.
Advertisements

PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Is this the “spioenkop” for CABG?
Is Carotid Stenting an Option for Treatment of Carotid Stenosis? Joint Hospital Surgical Grand Round WH WONG Queen Mary Hospital.
Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy Presented by Jay Yadav, MD on behalf of the SAPPHIRE Investigators.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Stenting with or without Protection in High-Risk Patients with Moderate to High-Grade Carotid Stenosis Presented at ACC 2003 Late Breaking Clinical Trials.
Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006 Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006.
Carotid Endarterectomy versus Stenting: Where do we stand today? Vascular Conference March 23, 2010.
Endovascular Management of Intracranial and Extracranial Atherosclerosis Rishi Gupta, MD Associate Professor of Neurology, Neurosurgery, and Radiology.
CORONARY PRESSURE MEASURENT AND FRACTIONAL FLOW RESERVE
20 Cardiovascular Disease and Physical Activity chapter.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Simultaneous Coronary Artery Bypass and Carotid Endarterectomy Ye zhidong, Liu Peng Department of Cardiovascular Surgery China-Japan Friendship Hospital.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
Epidemiology in HK  Stroke is major cause of morbidity and mortality around the world  4th cause of mortality in HK resulting in >3000 deaths every.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
A Review of – Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Ted Williams Pharm D Candidate Monday Lab.
Carotid Disease – Stent vs Surgery vs Medical Therapy? Mehdi H. Shishehbor, DO, MPH, PhD Director, Endovascular Services Interventional Cardiology & Vascular.
CAROTID ARTERY ENDARTHERECTOMY &INTERVENTION
© Continuing Medical Implementation ® …...bridging the care gap Geriovascular Prevention Optimizing Prevention of Cardiovascular Disease in the Elderly.
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
Angela Aziz Donnelly April 5, 2016
Emerging Techniques For Management of Carotid and Brachiocephalic Occlusive Disease for Prevention of Stroke Brian Whang, Romeo Mateo, Anthony Pucillo,
Dr. Quan, Dr. Mirhashemi, Dr. Chiang
Clinical Outcomes with Newer Antihyperglycemic Agents
(p for noninferiority = 0.01)
Clinical Outcomes with Newer Antihyperglycemic Agents
Prediction and Prevention of Stroke in Patients with Symptomatic Carotid Stenosis: The High-risk Period and the High-risk Patient  P.M. Rothwell  European.
Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
Complex Ostial Disease of the Aortic Arch Vessels
Recent Update on Carotid Endarterectomy versus Carotid Artery Stenting
Critical Appraisal of the European CAS Trials
CQC Amit Gossain.
TAVI Passed the Exam and is Ready for Clinical Use in Inoperable Patients Disclosures Research Funding and Speaking Honoraria: Edwards Lifesciences.
CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.
HOPE: Heart Outcomes Prevention Evaluation study
Cardiovascular Research Technology Conference (CRT 17)
Women, Bleeding, and Coronary Intervention
Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck
PMA Analysis of the CREST Trial Approvability of the RX Acculink Carotid Stent System for Revascularization of Carotid Artery Stenosis in Standard Surgical.
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
FATS- Familial Atherosclerosis Treatment Study
Cardiovacular Research Technologies
Symptomatic vs. Asymptomatic Carotid Endarterectomy
Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival  Jessica B. Wallaert, MD, MS, Jack L. Cronenwett,
Comparison of carotid endarterectomy and stenting in real world practice using a regional quality improvement registry  Brian W. Nolan, MD, MS, Randall.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Carotid endarterectomy was performed with lower stroke and death rates than carotid artery stenting in the United States in 2003 and 2004  James T. McPhee,
National trends in utilization and postprocedure outcomes for carotid artery revascularization 2005 to 2007  Mohammad H. Eslami, MD, James T. McPhee,
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
O.L.Reuchlin gebruik van CT binnen de cardiogie
The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index.
The Cardiovascular Health Study:
Variation in smoking cessation after vascular operations
Preoperative risk factors for carotid endarterectomy: defining the patient at high risk  Amy B Reed, MD, Peter Gaccione, MA, Michael Belkin, MD, Magruder.
Philip P. Goodney, MD, Donald S. Likosky, PhD, Jack L. Cronenwett, MD 
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Volume 375, Issue 9719, Pages (March 2010)
Atlantic Cardiovascular Patient Outcomes Research Team
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Additional benefit of PCSK9 inhibition in high risk patients after myocardial infarction A FOURIER subanalysis Primary endpoint: composite of CV death,
Emily L. Spangler, MD, MS, Philip P
Transcarotid Artery Revascularization versus Transfemoral Carotid Artery Stenting for Treatment of Carotid Artery Stenosis Patric Liang, MD; Marc L.
Carotid artery stenting has increased rates of postprocedure stroke, death, and resource utilization than does carotid endarterectomy in the United States,
Presentation transcript:

Carotid Artery Stenosis Presentation by: Megan Burk, SPT

Outline Background Carotid Artery Stenosis Interesting Stats Tx’s (Revascularization) Stent/Angioplasty Recommendations/Indications Endarterectomy Endarterectomy VS stent Rehab- Preventative Care

Carotid Artery Stenosis Cause: Artery narrowing due to atherosclerosis; most common at bifurcation1 Moderate: 50%-69% stenosis1 Severe: 70%-99% stenosis1 Symptomatic: TIA or stroke Asymptomatic: Usually found incidentally or upon follow-up of abnormal auscultation on a physical exam1

Carotid Artery Stenosis Prevalence: <10% of the population has asymptomatic carotid artery stenosis of at least %50 or more1 Risk factors: People 65 y/o, CAD, PVD, DM, HTN, dyslipidemia, or risk factors for CVD1 Males affected 2:1 for asymptomatic carotid stenosis1

Interesting Stats ~35% of people who have TIAs will have a stroke within 5 years2 Of all strokes within the adult population, carotid stenosis is responsible for 20%. 3 In the U.S.:4 Stroke is #5 /10 top causes of death Over 795,000 have a stroke every year In 2009, 24% people that were in the hospital for a stroke were under 65 y/o

Revascularization methods Includes: Stent or endarterectomy Should be performed within 2 weeks of a TIA or stroke1 Indicated for patients with:1 Stenosis >50% No total occlusion No severe disability 2’ to infarct Other treatment methods: Medication therapy Treat risk factors

Stent Anatomy of vessels must be considered3 Considered an alternative to endart Stent preferred over endart if pt has:1 Uncorrectable CAD, heart failure, or COPD Scar tissue/fibrosis from prior procedure Prior cranial nerve injury Any lesion from body of C2 to clavicle

Endarterectomy Patients should be offered “endarterectomy as first choice, with carotid artery stenting reserved for patients at high surgical risk.” 3 Endart preferred over stent especially if:1 >70 y/o Lesions >15 mm

Endarterectomy VS stent 2014 study by Spangler5 et al. compared normal and high-risk cohorts of symptomatic vs asymptomatic patients. Large sample size: 11,880 patients 11,366 underwent endart & 544 underwent stent Normal risk: patients that fell under the lower 3 quartiles of risk score (based on 5-year mortalities risk score) High risk: Calculated by mortality risk score and a patient that has had CHF, open-heart sx within 6 weeks, recent MI, unstable angina, severe pulmonary disease, and age over 80 y/o. Results: For asymptomatic patients (normal and high risk): No significant difference between stent and endarterectomy revascularization outcomes in terms of in-hospital stroke and/or death For symptomatic patients: Significant difference: patients that had a stent had worse outcomes with death, stroke, and MI than patients after an endarterectomy. Normal risk patients had stroke or death rate of 1.3% with endart and 5.2% with stent. High risk patients had stroke or death rate of 1.5% with endart and 9.3% with stent.

Endarterectomy VS stent Results: No significant difference between endart and stent with intermediate to long-term all endpoint outcomes. Significant differences between short-term outcomes: Stroke or death rates: Endart: 5.4% Stent: 7.3% MI incidence rates (weighted from 4 trials): Endart: 2.6% Stent: 0.9% Cranial neuropathy Endart: 7.5% Stent: <1% <0.5% are permanent 2010 meta-analysis by Meier3 et al. included 11 articles comparing endart and stent for treating carotid artery stenosis (symptomatic or asymptomatic patients) and included short- term and intermediate to long- term outcomes of stroke, death, MI, facial neuropathy, and/or disabling stroke (endpoints). Sample size: 4,796 total patients from 11 studies.

Preventative measures Treat other risk factors: Lifestyle changes, smoking cessation, control blood pressure Patient education

References DynaMed Plus [Internet]. Ipswich (MA): EBSCO Information Services. 1995 - . Record No. 116305, Carotid artery stenosis repair; updated 2016 Jun 14, cited on 9 June 2017; Available from http://www.dynamed.com.cmich.idm.oclc.org/login.aspx?direct=true&site=DynaMed&id=116305. University of Michigan. 2000. http://www.med.umich.edu/lrc/coursepages/m1/anatomy2010/html/clinicalcases/endarterectomy/case.html Meier P, Knapp G, Tamhane U, Chaturvedi S, Gurm HS. Short term and intermediate term comparison of endarterectomy versus stenting for carotid artery stenosis: systematic review and meta-analysis of randomised controlled clinical trials. BMJ. 2010;340:c467. http://www.bmj.com/content/340/bmj.c467.full Legg, T. The top 10 leading causes of death in the United States. MNT; 2017. Retrieved from http://www.medicalnewstoday.com/articles/282929.php. Spangler EL, Goodney PP, Schanzer A, Stone DH, Schermerhorn ML, Powell RJ, Cronenwett JL, Nolan BW, Vascular Study Group of New England. Outcomes of carotid endarterectomy versus stenting in comparable medical risk patients. Journal of vascular surgery. 2014;60(5):1227-31. http://www.osric.com/bingo-card- generator/?title=Carotid+Artery+Stenosis&words=Revascularization%2C+Prevalence%3A+%3C10%25+of+the+population%2C+Moderate %3A+50%25-69%25%2C+Severe%3A+70%25-+99%25%2C+5%2F10+top+cause+of+death%2C+2014+meta-analysis%2C+2010+meta- analysis%2C+Patient+Education%2C+Smoking+Cessation%2C+Endarterectomy%2C+Stent%2C+High+Blood+Pressure%2C+Asymptomat ic%2C+Symptomatic%2C+Atherosclerosis%2C+Auscultation%2C+Bifurcation&freespace=false&freespaceValue=&freespaceSubheadingVa lue=Free+Space&freespaceRandom=false&width=4&height=4&number=15#results